Rafael Barrera, MD, Director of the Surgical Intensive Care Unit at Long Island Jewish (LIJ) Medical Center in New York, explains how human error derived from pharmacy-mixed total parenteral nutrition (TPN) can increase the probability for complications as a result of taking the medicine. He advises using industry-based FDA-approved products as they do not pose the same risks due to human error, which can increase the risk of infection or metabolic complications.

Reading:

Driscoll DF. Cholestasis induced by total parenteral nutrition. Clin Liver Dis. 2008 Feb;12(1):97-11365, viii.

Acca M, Ragno A, Francucci CM, D’Erasmo E. Metabolic bone diseases during long-term total parenteral nutrition. J Endocrinol Invest. 2007;30(6 Suppl):54-9.

Sponsored by The Doctor’s Channel